AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35745239 — intervention group
Group type: EXPERIMENTAL
Intervention: Dewaxed Coffee (DC)
Number of subjects: 40
Study 35745239 — intervention group
Group type: COMPARATOR
Intervention: Standard Coffee (SC)
Number of subjects: 40
Study 34051733 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram and risk classification system for predicting overall survival (OS) in SCLC patients with brain metastasis
Number of subjects: 3522
Study 34051733 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram and risk classification system
Number of subjects: 3522
Study 34051733 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 3522
Study 34051733 — intervention group
Group type: COMPARATOR
Intervention: Cox regression analysis
Number of subjects: 3522
Study 35477641 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-3070 7.6 mg/24 h
Number of subjects: 369
Study 35477641 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-3070 3.8 mg/24 h
Number of subjects: 369
Study 35477641 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369
Study 33367669 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFCA)
Number of subjects: 648
Study 35994019 — intervention group
Group type: EXPERIMENTAL
Intervention: Prewarming with forced-air warming (FAW) device
Number of subjects: 104
Study 32281404 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavitary tissue plasminogen activator (tPA)
Number of subjects: 28
Study 32281404 — intervention group
Group type: COMPARATOR
Intervention: Saline treatment
Number of subjects: 28
Study 32717033 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain-responsive neurostimulation of the nucleus accumbens using the RNS® System (NeuroPace Inc) for LOC eating.
Number of subjects: 6
Study 33412344 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonnutritive sucking (NNS) twice a day for 10 days during two consecutive weeks
Number of subjects: 45
Study 33412344 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined program of NNS (15 min) and swallowing exercise (SE) (15 min) daily for 10 days during two consecutive weeks
Number of subjects: 45
Study 33412344 — intervention group
Group type: COMPARATOR
Intervention: Routine NICU care
Number of subjects: 45
Study 33848307 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure essential oil therapy (sandalwood)
Number of subjects: 43
Study 33848307 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended essential oil therapy (sandalwood-lavender)
Number of subjects: 43
Study 33848307 — intervention group
Group type: COMPARATOR
Intervention: Control (no essential oil)
Number of subjects: 43
Study 33362439 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm Release Technique (DRT)
Number of subjects: 14
Study 33362439 — intervention group
Group type: EXPERIMENTAL
Intervention: Rib Mobilization Technique + Diaphragm Release Technique (RMT+DRT)
Number of subjects: 14
Study 34661770 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal pad of fat sandwiched with a nasolabial flap (Group I)
Number of subjects: 40
Study 34661770 — intervention group
Group type: COMPARATOR
Intervention: Buccal pad of fat combined with a collagen graft (Group II)
Number of subjects: 40
Study 34876412 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide to Action for Care Homes (GtACH) multifactorial fall prevention programme
Number of subjects: 1657
Study 34876412 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1657
Study 34876412 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide to Action for Care Homes (GtACH)
Number of subjects: 1657
Study 33065181 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based IGBT with ureteral dose D0.1cm3 ≥77 Gy
Number of subjects: 242
Study 33065181 — intervention group
Group type: COMPARATOR
Intervention: MRI-based IGBT with ureteral dose D0.1cm3 <77 Gy
Number of subjects: 242
Study 33065181 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based IGBT with ureteral dose D0.1cm3 ≥85 Gy
Number of subjects: 242
Study 33065181 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based IGBT with ureteral dose D0.1cm3 ≥90 Gy
Number of subjects: 242
Study 33065181 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based IGBT without pre-existing hydronephrosis
Number of subjects: 242
Study 33065181 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based IGBT with late grade ≥3 US
Number of subjects: 242
Study 34013470 — intervention group
Group type: EXPERIMENTAL
Intervention: SHE (brief motivational interviewing and psychoeducation‐based computerized intervention)
Number of subjects: 153
Study 34013470 — intervention group
Group type: COMPARATOR
Intervention: Control group (screen and referral‐only condition)
Number of subjects: 153
Study 34498740 — intervention group
Group type: EXPERIMENTAL
Intervention: High-throughput sequence-based method for predicting extant fold switchers; method leverages JPred4 predictions of ?-helix to ?-strand discrepancies.
Number of subjects: 99
Study 34498740 — intervention group
Group type: EXPERIMENTAL
Intervention: Classifier developed from predicted discrepancies and overall percentage of predicted secondary structure.
Number of subjects: 99
Study 32219775 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage lymph node dissection (SLND)
Number of subjects: 0
Study 32219775 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA PET/CT imaging
Number of subjects: 0
Study 32219775 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA radioguided surgery
Number of subjects: 0
Study 33028559 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing with moisturising care
Number of subjects: 26
Study 33028559 — intervention group
Group type: COMPARATOR
Intervention: Standard supportive care (moisturising care alone)
Number of subjects: 26
Study 615919275 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg RBZ
Number of subjects: 759
Study 615919275 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg RBZ
Number of subjects: 759
Study 615919275 — intervention group
Group type: COMPARATOR
Intervention: Sham/crossover
Number of subjects: 759
Study 35484175 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine
Number of subjects: 115
Study 35484175 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine plus MgSO4
Number of subjects: 115
Study 35484175 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO4
Number of subjects: 115
Study 35484175 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 115
Study 34869434 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricothyroid membrane puncture anesthesia
Number of subjects: 70
Study 34869434 — intervention group
Group type: COMPARATOR
Intervention: Topical anesthesia
Number of subjects: 70
Study 35587540 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 25 μg followed by 50 μg every 4 hours
Number of subjects: 47
Study 35587540 — intervention group
Group type: COMPARATOR
Intervention: Buccal misoprostol 25 μg followed by 50 μg every 4 hours
Number of subjects: 47
Study 32649584 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive educational workshop with standardized patients (SPs)
Number of subjects: 62
Study 32649584 — intervention group
Group type: COMPARATOR
Intervention: Interactive educational workshop without standardized patients (SPs)
Number of subjects: 62
Study 35278780 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral grief therapy (ICBGT)
Number of subjects: 57
Study 34621545 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene cover
Number of subjects: 156
Study 34621545 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene cover plus artificial tear drops
Number of subjects: 156
Study 34621545 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene cover plus Lubratex eye ointment
Number of subjects: 156
Study 34621545 — intervention group
Group type: COMPARATOR
Intervention: Routine interventions (control eye)
Number of subjects: 156
Study 34392146 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/day anthocyanins for 12 weeks
Number of subjects: 93
Study 34392146 — intervention group
Group type: EXPERIMENTAL
Intervention: 320 mg/day anthocyanins for 12 weeks
Number of subjects: 93
Study 34392146 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-response relationship of anthocyanins
Number of subjects: 93
Study 34392146 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in platelet aggregation
Number of subjects: 93
Study 34392146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 33291311 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrating roller
Number of subjects: 23
Study 33291311 — intervention group
Group type: COMPARATOR
Intervention: Foam roller
Number of subjects: 23
Study 36224664 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-based counselling with a cognitive-behavioural approach
Number of subjects: 92
Study 33899649 — intervention group
Group type: COMPARATOR
Intervention: MET 1000 mg alone
Number of subjects: 18
Study 33899649 — intervention group
Group type: EXPERIMENTAL
Intervention: FOT 24 mg and MET
Number of subjects: 18
Study 33899649 — intervention group
Group type: EXPERIMENTAL
Intervention: FOT 24 mg alone
Number of subjects: 18
Study 616542999 — intervention group
Group type: EXPERIMENTAL
Intervention: Student question creation exercise
Number of subjects: 84
Study 616542999 — intervention group
Group type: COMPARATOR
Intervention: Traditional case‐based application exercise
Number of subjects: 84
Study 35158205 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (20 mg/kg/i.v. every 4 weeks for 12 months)
Number of subjects: 86
Study 35158205 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (in PD-L1-positive group)
Number of subjects: 86
Study 35158205 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in PD-L1-positive group)
Number of subjects: 86
Study 35158205 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (in PD-L1-negative group)
Number of subjects: 86
Study 35158205 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in PD-L1-negative group)
Number of subjects: 86
Study 33693703 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17-beta estradiol 0.1 mg/day with 30 mcg/kg/dose of rhIGF-1 administered subcutaneously twice daily (AN-IGF-1+)
Number of subjects: 75
Study 33693703 — intervention group
Group type: COMPARATOR
Intervention: Transdermal 17-beta estradiol 0.1 mg/day with placebo (AN-IGF-1-)
Number of subjects: 75
Study 32639592 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 33
Study 32639592 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 33
Study 36188367 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasimelteon
Number of subjects: 0
Study 36188367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33487271 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (500 mg)
Number of subjects: 88
Study 33487271 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) (600 mg) and probiotic
Number of subjects: 88
Study 33487271 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA)
Number of subjects: 88
Study 33487271 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 34554264 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Process Training (APT)
Number of subjects: 51
Study 34554264 — intervention group
Group type: COMPARATOR
Intervention: Activity‐based Attention Training (ABAT)
Number of subjects: 51
Study 34189933 — intervention group
Group type: EXPERIMENTAL
Intervention: PeerFIT group lifestyle intervention
Number of subjects: 150
Study 34189933 — intervention group
Group type: COMPARATOR
Intervention: BEAT one‐on‐one mHealth coaching
Number of subjects: 150
Study 34258785 — intervention group
Group type: EXPERIMENTAL
Intervention: k-resolution sequential randomization (k-RSR) procedure
Number of subjects: 0
Study 34258785 — intervention group
Group type: COMPARATOR
Intervention: pairwise sequential randomization (PSR) procedure
Number of subjects: 0
Study 32187404 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful cold
Number of subjects: 38
Study 32187404 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful, unpleasant and pleasant mechanical stimuli
Number of subjects: 38
Study 32187404 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleasant mechanical stimulus
Number of subjects: 38
Study 32187404 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal or mechanical stimuli
Number of subjects: 38
Study 32187404 — intervention group
Group type: COMPARATOR
Intervention: Control stimuli
Number of subjects: 38
Study 35246206 — intervention group
Group type: EXPERIMENTAL
Intervention: Swine dermal collagen prosthesis implanted preperitoneally as a prophylactic procedure
Number of subjects: 90
Study 35246206 — intervention group
Group type: COMPARATOR
Intervention: Normal wall abdominal closure
Number of subjects: 90
Study 34006077 — intervention group
Group type: EXPERIMENTAL
Intervention: Photofunctionalised implant
Number of subjects: 34
Study 34006077 — intervention group
Group type: COMPARATOR
Intervention: Untreated implant (control group)
Number of subjects: 34
Study 33905790 — intervention group
Group type: EXPERIMENTAL
Intervention: Decentering
Number of subjects: 108
Study 33905790 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualisation
Number of subjects: 108
Study 33905790 — intervention group
Group type: COMPARATOR
Intervention: Mind-wandering control
Number of subjects: 108
Study 32008434 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine sodium-potassium ratio (UNa/UK)
Number of subjects: 478311
Study 32008434 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine albumin adjusted for creatinine
Number of subjects: 478311
Study 32008434 — intervention group
Group type: EXPERIMENTAL
Intervention: UNa/UK and urine albumin adjusted for creatinine
Number of subjects: 478311
Study 35817759 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth with anxiety
Number of subjects: 105
Study 35817759 — intervention group
Group type: COMPARATOR
Intervention: No psychiatric diagnosis (ND)
Number of subjects: 105
Study 35817759 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-reported sleep problems
Number of subjects: 105
Study 34617916 — intervention group
Group type: EXPERIMENTAL
Intervention: PedAMINES mobile app
Number of subjects: 150
Study 34617916 — intervention group
Group type: COMPARATOR
Intervention: Conventional preparation methods
Number of subjects: 150
Study 32156838 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (Group A)
Number of subjects: 201
Study 32156838 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline plus N‐acetylcysteine (1200mg twice a day for 2 days) (Group B)
Number of subjects: 201
Study 32156838 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline plus daily alpha tocopherol (600 IU once daily from one day before till 2 days after angiography for 4 days) (Group C)
Number of subjects: 201
Study 35429246 — intervention group
Group type: EXPERIMENTAL
Intervention: CHP‐NY‐ESO‐1 vaccination
Number of subjects: 54
Study 35429246 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 54
Study 34090982 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies designed to mimic RCTs
Number of subjects: 0
Study 34090982 — intervention group
Group type: EXPERIMENTAL
Intervention: Target trial framework
Number of subjects: 0
Study 34090982 — intervention group
Group type: EXPERIMENTAL
Intervention: Design elements of RCTs
Number of subjects: 0
Study 34090982 — intervention group
Group type: EXPERIMENTAL
Intervention: Example target trial emulating TRITON-TIMI-38
Number of subjects: 0
Study 33217362 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CoronaVac (3 μg per 0.5 mL)
Number of subjects: 743
Study 33217362 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose CoronaVac (6 μg per 0.5 mL)
Number of subjects: 743
Study 33217362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 743
Study 37232538 — intervention group
Group type: EXPERIMENTAL
Intervention: Urotherapy and parasacral TENS (20 sessions, 3 times weekly, 20 min each, 10 Hz frequency, 700 μS pulse width)
Number of subjects: 72
Study 37232538 — intervention group
Group type: COMPARATOR
Intervention: Urotherapy (control group)
Number of subjects: 72
Study 33563987 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in optional components
Number of subjects: 451306
Study 33563987 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer educational duration, older menarche, taller stature
Number of subjects: 451306
Study 33563987 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of adiposity, dyslipidaemia, neuroticism, Alzheimer’s, schizophrenia
Number of subjects: 451306
Study 33136172 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day ART
Number of subjects: 79
Study 33136172 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day ART
Number of subjects: 79
Study 33136172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 34260454 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 IU Botulinum Toxin (BT) injection at 1 point per side (2‐points group)
Number of subjects: 40
Study 34260454 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 IU Botulinum Toxin (BT) injection at 2 points per side (4‐points group)
Number of subjects: 40
Study 33797076 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD10 (10 mg/kg/day)
Number of subjects: 396
Study 33797076 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD20 (20 mg/kg/day)
Number of subjects: 396
Study 33797076 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396
Study 33797076 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD (both doses)
Number of subjects: 396
Study 35272303 — intervention group
Group type: EXPERIMENTAL
Intervention: FASD (force-activated separation device)
Number of subjects: 302
Study 35272303 — intervention group
Group type: COMPARATOR
Intervention: SOC (standard of care)
Number of subjects: 302
Study 35272303 — intervention group
Group type: EXPERIMENTAL
Intervention: FASD
Number of subjects: 302
Study 35272303 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 302
Study 32814667 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-up oral food challenge testing (SOFT)
Number of subjects: 55
Study 32814667 — intervention group
Group type: COMPARATOR
Intervention: Home incrementing group
Number of subjects: 55
Study 32814667 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 55
Study 35348351 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable norethisterone enanthate (Net‐En)
Number of subjects: 94
Study 35348351 — intervention group
Group type: EXPERIMENTAL
Intervention: Etonorgesterol/ethinyl estradiol vaginal ring (NuvaRing)
Number of subjects: 94
Study 35348351 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 94
Study 35348351 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent subclinical Candida colonization
Number of subjects: 94
Study 35348351 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of Candida hyphae
Number of subjects: 94
Study 35348351 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical Candida colonization
Number of subjects: 94
Study 33176845 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3 mg IV)
Number of subjects: 122
Study 33176845 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg IV)
Number of subjects: 122
Study 33176845 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 122
Study 33807285 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention aimed at improving information on cardiovascular risk; details on dosage and duration not specified
Number of subjects: 464
Study 33807285 — intervention group
Group type: COMPARATOR
Intervention: Usual care; details not specified
Number of subjects: 464
Study 33008479 — intervention group
Group type: EXPERIMENTAL
Intervention: Kampo medicine (kakkonto and shosaikotokakikyosekko) administered 2.5 g of KT and 2.5 g of SSKKS three times a day for 14 days in addition to conventional treatment.
Number of subjects: 150
Study 33008479 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with antipyretics, painkillers, or antitussives.
Number of subjects: 150
Study 34852855 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI neurofeedback targeting self-blaming emotions
Number of subjects: 43
Study 34852855 — intervention group
Group type: COMPARATOR
Intervention: Self-guided psychological intervention
Number of subjects: 43
Study 34852855 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI neurofeedback
Number of subjects: 43
Study 34852855 — intervention group
Group type: COMPARATOR
Intervention: Self-guided psychological strategies
Number of subjects: 43
Study 34332796 — intervention group
Group type: EXPERIMENTAL
Intervention: Sof-Lex discs
Number of subjects: 72
Study 34332796 — intervention group
Group type: COMPARATOR
Intervention: Sof-Lex Spiral Wheels
Number of subjects: 72
Study 32675606 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy (Xinmiao treatment system, >3 days/week, >1 h/day)
Number of subjects: 99
Study 616663253 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom-based crew resource management courses
Number of subjects: 0
Study 616663253 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based crew resource management courses
Number of subjects: 0
Study 616663253 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of classroom and simulation-based courses
Number of subjects: 0
Study 616663253 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative data analysis
Number of subjects: 0
Study 34397270 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 60
Study 34397270 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 60
Study 34235853 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 1075
Study 34235853 — intervention group
Group type: EXPERIMENTAL
Intervention: Doing competitive sport
Number of subjects: 1075
Study 34235853 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 1075
Study 34235853 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental history of LBP
Number of subjects: 1075
Study 34235853 — intervention group
Group type: COMPARATOR
Intervention: Weight of schoolbags
Number of subjects: 1075